In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
A team of researchers at Baylor College of Medicine and Roswell Park Comprehensive Cancer Center has identified a long sought after connection between how cancer cells use glucose to generate energy and cancer growth.
Dr. Jeffrey A. Bluestone, the A.W. and Mary Margaret Clausen Distinguished Professor at the University of California San Francisco, will be the Distinguished Lecturer at the Seventh Annual McNair Symposium at Baylor College of Medicine.
The Department of Molecular and Human Genetics and the Dan L Duncan Comprehensive Cancer Center hosted their first joint U.S.-Japan Clinical Cancer Genomics and Personalized Medicine Symposium in Tokyo, Japan.